This inventor holds 3 USPTO granted patents. Top assignee: Millennium Health, LLC. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Xiequn Xu: Innovator in Genetic Biomarkers
Introduction
Xiequn Xu is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of genetics, particularly in the identification of biomarkers for drug reactions. With a total of 3 patents, his work is crucial for advancing personalized medicine.
Latest Patents
One of Xiequn Xu's latest patents is focused on a novel single nucleotide polymorphism (SNP) in HLA-B*15:02. This SNP can be utilized as a biomarker for predicting carbamazepine-induced severe adverse skin reactions in Asian populations. The patent outlines methods and reagents for assessing this specific SNP, which can help in predicting an increased risk of these severe reactions. This innovation is vital for improving patient safety and treatment outcomes.
Career Highlights
Xiequn Xu is currently associated with Millennium Health, LLC, where he continues to work on groundbreaking research in pharmacogenomics. His expertise in genetic markers has positioned him as a key player in the field, contributing to the understanding of drug interactions and patient responses.
Collaborations
Xiequn Xu collaborates with notable colleagues, including Hua Fang and Tanya Moreno. Their combined efforts enhance the research output and innovation at Millennium Health, LLC.
Conclusion
Xiequn Xu's work in identifying genetic biomarkers is paving the way for safer and more effective medical treatments. His contributions are essential for the future of personalized medicine and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile